Evidence map›Paper›PMID 35328823›Full record

ReviewInternational journal of molecular sciences2022

Mechanisms and Applications of Bacterial Sporulation and Germination in the Intestine.

Nienke Koopman, Lauren Remijas, Jurgen Seppen, Peter Setlow, Stanley Brul

Open access · goldAbstract readReview
In one paragraph

Review in International journal of molecular sciences, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed
4.4field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 48 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Review
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Winning the battle of intestinal peace withFrontiers in microbiology · 2025
    Review
  14. Article
  15. Uncovering newMicrobiology spectrum · 2024
    Article
  16. Microbes as medicine.Annals of the New York Academy of Sciences · 2024
    Review
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 2 countries.

Nienke KoopmanSwammerdam Institute for Life Sciences (SILS), University of Amsterdam, 1098 XH Amsterdam, The Netherlands.ORCID 0000-0002-2831-0938
Lauren RemijasSwammerdam Institute for Life Sciences (SILS), University of Amsterdam, 1098 XH Amsterdam, The Netherlands.ORCID 0000-0003-1895-7276
Jurgen SeppenTytgat Institute for Liver and Intestinal Research, Amsterdam University Medical Centers, Location AMC, 1105 BK Amsterdam, The Netherlands.ORCID 0000-0001-9689-9919
Peter SetlowDepartment of Molecular Biology and Biophysics, UConn Health, 263 Farmington Avenue, Farmington, CT 06030-3305, USA.
Stanley BrulSwammerdam Institute for Life Sciences (SILS), University of Amsterdam, 1098 XH Amsterdam, The Netherlands.ORCID 0000-0001-5706-8768
Netherlands Institute for Neuroscience · NLAmsterdam University Medical Centers · NLUConn Health · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Recent studies have suggested a major role for endospore forming bacteria within the gut microbiota, not only as pathogens but also as commensal and beneficial members contributing to gut homeostasis. In this review the sporulation processes, spore properties, and germination processes will be explained within the scope of the human gut. Within the gut, spore-forming bacteria are known to interact with the host's immune system, both in vegetative cell and spore form. Together with the resistant nature of the spore, these characteristics offer potential for spores' use as delivery vehicles for therapeutics. In the last part of the review, the therapeutic potential of spores as probiotics, vaccine vehicles, and drug delivery systems will be discussed.

Indexed as

Gastrointestinal MicrobiomeProbioticsBacteriaHumansIntestinesSpores, Bacterialdrug delivery systeminflammatory bowel diseasemicrobiomeprobioticssporesporobiotavaccine vehicle

Identifiers

PMID35328823
PMCPMC8953710
OpenAlexW4220909182

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.